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Definition and goals of home mechanical ventilation Born during the polio epidemics of 50 years ago, home mechanical ventilation has evolved towards two distinct concepts-a life support system for patients without respiratory independence (high cervical spinal cord injury, end stage neuromuscular disease, or chronic obstructive pulmonary disease), and elective therapy for patients with progressive chronic respiratory insufficiency (mostly restrictive parietal or neuromuscular insufficiency) which prevents acute respiratory failure, preserves function, and increases survival. ' Patients on home mechanical ventilation use their respirator intermittently (at least three hours per day) or continuously, with either a tracheostomy, a mouthpiece, or a face or nasal mask, or an external device such as a cuirass or a poncho suit. Consequently, home mechanical ventilation is the longer term application of ventilatory support to patients who are no longer in acute respiratory failure and do not need the sophistication of an intensive care unit.'
According to the guidelines for long term mechanical ventilation published by a task force of the American College of Chest Physicians,2 the goals of home mechanical ventilation must include the following: (1) extend life; (2) enhance the quality of life; (3) provide an environment which will enhance individual potential; (4) reduce morbidity; (5) improve physical and physiological function; and (6) be cost beneficial.
Several meetings and consensus conferences"3have emphasised the importance of identifying the problems relative to equipment, the assessment of individual needs, appropriate levels of care, and adequate long term reimbursement which have been treated differently in most countries. Long term home mechanical ventilation was introduced into clinical practice more than 50 years ago when the iron lung made survival possible for thousands of patients with poliomyelitis and other diseases associated with neuromuscular ventilatory failure.
After the acute phase of the illness the presence of severe motor damage, sometimes with total respiratory paralysis, required life long respiratory support compatible with management in the home. 4 The 1 950s marked a period of rapid progress in technology, with the development of endotracheal ventilation and tracheostomy, and improved survival after acute respiratory failure,5 as reported by Robert et al6 in an important retrospective study which included patients with chronic respiratory insufficiency from several causes. After the eradication of poliomyelitis, improvements of mechanical ventilation techniques were mainly concerned with managing acute respiratory failure using continuous positive pressure ventilation, although there was also interest in phrenic nerve stimulation for patients with cervical cord injuries unable to achieve an adequate level of respiration.7 Interest was also turning towards patients with chronic respiratory insufficiency due to chronic obstructive pulmonary disease (COPD) In chronic neuromuscular diseases there is reduced distensibility of the respiratory system secondary to the lowering of chest wall and lung compliance. It explains the important reduction of vital capacity, and causes the elastic work linked to breathing to increase. It could also explain the adoption of the typical respiratory pattern of a low tidal volume and a high respiratory rate. If there is no compensatory increase of minute ventilation, hypercapnia results.
Respiratory muscle fatigue may also cause a reduction in inspiratory time and tidal volume and, if it is severe, reduce minute ventilation. '9 In chronic respiratory insufficiency secondary to muscle disease or chest deformity the respiratory muscles are prone to acute or chronic fatigue as their energy requirements are increased above energy intake. 20 It is also possible that hypercapnia in restrictive lung diseases is the result of an inadequate response of the respiratory centres. It is well known that nocturnal hypoventilation appears early during follow up of the causal disease, before diurnal hypoventilation. Alteration of nocturnal gas exchange could progressively reduce the sensitivity of the central and peripheral chemoreceptors and thus enhance the amplitude of diurnal hypercapnia.
In most of these patients, therefore, nocturnal respiratory assistance may improve the diurnal level of hypercapnia by several mechanisms including an improvement of pulmonary and thoracic compliance secondary to breathing with large tidal volumes during the night, resting of the respiratory muscles,2' and resting respiratory drive to a normal level following correction of the nocturnal alterations of gas exchange.22
PATIENTS WITH COPD
Long term mechanical ventilation causes several changes to occur in respiratory control and performance. The correction of arterial blood gases is one of the principal objectives which determines the adjustment of the settings on the respirator. Home mechanical ventilation is preferably used at night to correct the episodes of arterial oxygen desaturation that occur during rapid eye movement (REM) sleep when the patient breathes ambient air. 23 The improvement in nocturnal Pao2 can also increase the diurnal Pao2,2425 an effect that can be related to the improvement of alveolar-arterial oxygen gradients and to an improved level of spontaneous ventilation following mechanical ventilation. This could reflect better compliance of the chest wall and lungs, improved respiratory muscle function, increased respiratory drive, a lowering of minute oxygen consumption due to a decrease in the work of breathing, or an increase in the efficiency of the respiratory muscles. If the cardiac output remains unaltered, this may provide a higher Pao2. 26 The reduction in Paco2 is a sign of improvement in alveolar ventilation with mechanical ventilation which can persist temporarily after discontinuing support, and could be associated with a change in the pattern of breathing to one more favourable to alveolar ventilation. 27 The respiratory centre may recover its CO2 sensitivity which had become blunted. 28 The increase in lung volumes (FRC, FVC) and compliance29 in emphysematous patients could limit the efficiency of home ventilation and could even aggravate underlying disease. 20 The most important effect seems to be the reduction of respiratory muscle fatigue in emphysematous patients whose respiratory muscles become disadvantaged by the very large lungs, and who are also subjected to an increase in respiratory work due to the increased resistance of the respiratory tract.25 It is clear, however, that there is a balance between potential benefit for emphysematous patients and the increase in the pulmonary inflation caused by mechanical ventilation. 30 The long term haemodynamic effects of home mechanical ventilation are mainly secondary to the correction of the hypoxaemia and the reduction of consequent pulmonary hypertension. In addition, improved function of the right ventricle can occur,3" as well as an increase in cardiac output. Secondary polycythaemia is also controlled by the improvement of Pao2.
The red cell mass is correlated to the mean level of Sao, and the lowest nocturnal Sao,.
In patients with COPD tracheostomy itself could be of value for several reasons32:
(1) reduction of the anatomical dead space; (2) facilitation of endotracheal aspiration and drainage; (3) facilitation of endotracheal ventilation; (4) possible reduction of the airway resistance with subsequent reduction in the respiratory work; (5) modification of FRC (as tracheostomy makes "pursed lips" breathing no longer possible, a reduction in FRC can occur, which is also assisted by a reduction of airways resistance); (6) inhibition of obstructive apnoeas which are present in the "overlap syndrome"-that is, the association of COPD and the sleep apnoea syndrome. with neuromuscular and skeletal disorders with a five year survival rate of 70-80%, and associated with a reduction in admission to hospital for respiratory failure (tables 2 and 3). 6 The obesity-hypoventilation syndrome36 should be a good indication but warrants further investigation. '7 Patients with COPD acute on chronic respiratory failure: should they be ventilated? '6 Respiratory intensive care has a major influence on the survival rates of patients with acute respiratory failure due to COPD.'839 In these patients acute respiratory failure is caused by disease progression or an acute event such as bronchial infection, bronchospasm, pulmonary emboli, or cardiac failure associated with chronic airway obstruction. '8 There is general agreement that mechanical ventilation should be avoided in patients with severe chronic respiratory insufficiency as it is associated with great difficulty in weaning.404' The prognosis for those patients with COPD who survive an episode of acute respiratory failure also remains controversial.42 Hospital mortality has varied from 6% to 38%,43 44 the need for intubation from 4% to 54%,43 4546 and the two year survival from 25% to 68%.46-50 These differences in outcome may arise from differences in patient selection and definitions of COPD46 as well as from inconsistencies in defining the causes and severity of acute respiratory failure. 48 In most series COPD has only been defined by clinical criteria or by radiological signs of hyperinflation, and pulmonary function tests were not available for all patients.45 Asthmatic patients have not always been excluded from these studies. The precipitating cause of the acute respiratory failure is also important, as the mortality rate secondary to infection (20%) is very different from that secondary to heart failure (40%).47 There is also disagreement about defining the severity of acute respiratory failure, although it is generally accepted that this requires initial arterial blood gases breathing air of a Pao, < 7 kPa (<50 mm Hg) and Thus, most patients with COPD survive an episode of acute respiratory failure, even if the subsequent prognosis for survival is poor and similar to that of other patients with COPD without an episode of acute respiratory failure, both being strongly related to the severity of the underlying process. In common practice, the overlap syndrome33 associates COPD and sleep apnoea. Relief of upper airway obstruction may be necessary, but if the hypoxia is due at least in part to hypopnoeas and apnoeas, home mechanical ventilation should be considered. In the ANTADIR study56 there was a better prognosis for overweight patients undergoing home mechanical ventilation via a tracheostomy for the overlap syndrome. These results were confirmed in a recent multicentre study using nasal mask ventilation for patients with mented by any study comparable to that of Anthonisen et al'3 for IPPB, although there are many uncontrolled or retrospective studies.8 64 In the French home mechanical ventilation programmes, the number of patients treated with mouth IPPV has decreased greatly in recent years, initially with an increase in the use of tracheal ventilation6"7 and, more recently, nasal mask ventilation. '5 68 Home mechanical ventilation via tracheostomy (HMVT) The major interest of HMVT is the technical opportunity for prolonged mechanical ventilation sessions, especially during the night. Apart from the psychological effects, the existence of a tracheostomy in itself reduces the resistance of the upper airways and respiratory dead space, facilitates aspiration, and alleviates some work of breathing. 2632 The disadvantages are that it is invasive, requiring more support and ideally an adherence to a general programme of rehabilitation,'4 and requires home care support and has a socioeconomic cost. The risks include tracheal stenosis, although according to the results of the multicentre study coordinated by the ANTADIR the incidence is low, with 14 cases reported in 256 patients with COPD. 56 The long term results of HMVT have been evaluated by Robert et al 6 e-ineffective treatment. After reference 88. NEGATIVE INTERMITTENT PRESSURE VENTILATION (NIPV) NIPV was introduced by Dalziel in 1832, but its real use began with Drinker who built the first reliable iron lung in 1928. Emerson further improved it and its real use was during the polio epidemics of 50 years ago,78 reducing mortality by 50%.26 NIPV has been used in other neuromuscular diseases, and appeared useful in cases of muscular dystrophy, kyphoscoliosis, and also in patients with post-tuberculosus fibrosis. 79 Use of NIPV has recently been reconsidered for patients with COPD through new devices using light shells and jackets (poncho, wrap, or cuirass) applied around the thorax and upper abdomen. 80 Several trials are being conducted to ascertain whether the respiratory muscles can be rested with benefit. Preliminary results show that there is a real effect on the level of dyspnoea, on the control of diaphragmatic activity, and on improving the respiratory muscle strength.7981 NIPV seems better tolerated by patients with type B COPD than by those with emphysema in terms of levels of dyspnoea. However, other studies82 failed to confirm these early results.
Apparatus

VENTIIATORS
Ventilators for IPPV are generally used for long periods of time, often overnight. Most of them are volume cycled and they should be simple, reliable, and easy for the patient to adjust. For patients with COPD who are generally only partially dependent on their machine, the need for a battery operated ventilator is mandatory, which should also be light and portable. Both high and low pressure alarms are needed to indicate airflow obstruction, disconnection, or failure of the ventilator. These alarms must be independent of any external power source.~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~. In Europe several types of ventilator are commonly used, the Monnal D (CFPO) respirator being the most popular. Many other IPPV ventilators are available (fig 4) . Negative pressure generators are also available including the Myoclet in France, the Newmarket pump in the UK, the Emerson iron lung, the Portalung, and the Lifecare 170C which has recently been improved in the USA.
Simple patterns of ventilation are used with controlled rather than assisted or controlledassisted mode (VT 10-15 ml/kg with a cuffed tracheostomy tube, 15-20 ml/kg using nasal mask; inspiratory/expiratory ratio (I/E) 1/2; a respiratory rate of 12-18/min; Fio2 < 35%). Supplemental oxygen can be provided by cylinders, liquid oxygen, or a concentrator.
In addition to nasal CPAP generators, bilevel pressure preset ventilators (BIPAPO) are now available which allow the ventilator to cycle between a preset inspiratory and expiratory airway pressure. 83 equipped with a cuffed tracheostomy tube, which will be deflated as soon as possible to minimise the chances of later tracheal stenosis. If the respiratory status is compatible with it, the patient will then be ventilated through a speaking tracheostomy cannula.
Humidification of the inspired air is necessary during IPPV and after tracheostomy. In clinical practice two distinct situations are present: (1) the patient who has stayed in the intensive care unit, has a tracheostomy, but cannot be weaned from the respiratory support; and (2) the patient with chronic progressive hypoxia and hypercapnia in whom non-invasive assisted ventilation might be more useful than oxygen therapy alone. The majority of the patients are of this type, with a slowly progressive worsening of their hypercapnia and clinical status. HOME CARE TEAM MEMBERS Once the physician, patient, and family have decided that a return to home is feasible, an overall assessment of the patient and home is The key elements of pulmonary rehabilitation87 which will get the patient home with a respirator are (1) education about the disease and management of its treatment-that is, home mechanical ventilation; (2) physical therapy; (3) exercise conditioning (adapted to those severely disabled patients) and breathing retraining; (4) psychosocial counselling; and (5) vocational training.88
